INCYTE CORPORATION Long-Term Debt
INCYTE CORPORATION (INCY) had Long-Term Debt of $316.15 million as of 2011-12-31, per its 10-K filed 2012-02-22.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermDebtNoncurrent · last filed 2012-02-22
- 2011-12-31: Long-term Debt, Excluding Current Maturities $316.15M.
- 2010-12-31: Long-term Debt, Excluding Current Maturities $293.43M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2011-12-31 | $316.15M 10-K · filed 2012-02-22 |
| 2010-12-31 | $293.43M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |